HBIO
HBIO
NASDAQ · Life Sciences Tools & Services

Harvard Bioscience Inc

$0.50
+0.02 (+4.92%)
As of Feb 8, 2:24 PM ET ·
Analyst Consensus
Strong Buy
8
Analysts
Moderate
Coverage
Buy 6 75%
Hold 2 25%
Sell 0 0%
Price Target
Analyst Price Target +7,119.3% upside
Low Target $24.20
Average Target $35.75
High Target $46.73
Current Price $0.50
Current
$0.50
Target
$35.75
$24.20 $35.75 avg $46.73
Scenario Analysis
Bear Case
$24.20
4,786.9%
Low target
Base Case
$35.75
+7,119.3%
Avg target
Bull Case
$46.73
+9,336.6%
High target
Risk/Reward
2.0x
Balanced
Price in Context
52-Week High
$40.45
-98.8% from high
52-Week Low
$19.42
+-97.5% from low
Target vs 52W High
$35.75
-11.6% vs high
Peer Consensus — Life Sciences Tools & Services
Stock Consensus Analysts Buy % Target Upside
TMO
Thermo Fisher Scientific Inc
Strong Buy 33 82% $369.21 -32.0%
DHR
Danaher Corp
Strong Buy 31 87% $158.11 -27.0%
A
Agilent Technologies Inc
Buy 29 72% $64.69 -50.1%
IQV
Iqvia Holdings Inc
Strong Buy 30 80% $82.96 -55.8%
MTD
Mettler-Toledo International
Hold 21 43% $170.43 -87.6%
WAT
Waters Corp
Buy 25 56% $189.60 -50.3%
ILMN
Illumina Inc
Hold 26 50% $169.36 +41.5%
WST
West Pharmaceutical Services
Strong Buy 23 78% $136.24 -45.3%